New York, London, Bermuda, 11th December 2007 - Celtic Pharma, the global
private equity firm focused on the development of pharmaceuticals and biological
drugs, today announces that the firm's principals, Stephen Evans-Freke and John
Mayo CBE, are to launch two new follow-on funds targeting the pharmaceutical
industry's need for well developed products. Celtic Pharma's first fund, Celtic
Pharmaceutical Holdings L.P., is now over 75% committed and, once new
transactions that have agreed term sheets and are in legal documentation have
been completed, will be fully invested.
